No abstract available
MeSH terms
-
Amlodipine / administration & dosage
-
Amlodipine / pharmacology*
-
Amlodipine / therapeutic use*
-
Angiotensin II Type 1 Receptor Blockers / administration & dosage
-
Angiotensin II Type 1 Receptor Blockers / pharmacology*
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
-
Animals
-
Antihypertensive Agents / administration & dosage
-
Antihypertensive Agents / pharmacology*
-
Antihypertensive Agents / therapeutic use*
-
Biphenyl Compounds / administration & dosage
-
Biphenyl Compounds / pharmacology*
-
Biphenyl Compounds / therapeutic use*
-
Calcium Channel Blockers / administration & dosage
-
Calcium Channel Blockers / pharmacology*
-
Calcium Channel Blockers / therapeutic use*
-
Clinical Trials, Phase II as Topic
-
Drug Combinations
-
Drug Design
-
Humans
-
Hypertension / drug therapy*
-
Hypertension / etiology
-
Hypertension / physiopathology
-
Irbesartan
-
Tablets
-
Tetrazoles / administration & dosage
-
Tetrazoles / pharmacology*
-
Tetrazoles / therapeutic use*
-
Treatment Outcome
Substances
-
Angiotensin II Type 1 Receptor Blockers
-
Antihypertensive Agents
-
Biphenyl Compounds
-
Calcium Channel Blockers
-
Drug Combinations
-
Tablets
-
Tetrazoles
-
Amlodipine
-
Irbesartan